Lisdexamfetamine Dimesylate Tablet, Chewable
Takeda Pharmaceuticals USA Inc. · Available
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 07/14/2023
- Package NDC
- 59417-118-01
- Generic name
- Lisdexamfetamine Dimesylate Tablet, Chewable
- Contact info
- 877-TAKEDA-7 (1-877-825-3327)
- Availability
- Available
- Update date
- 09/15/2026
- Dosage form
- Tablet, Chewable
- Presentation
- Vyvanse, Tablet, Chewable, 40 mg (NDC 59417-118-01)
- Company name
- Takeda Pharmaceuticals USA Inc.
- Status
- Current
- Therapeutic category
- Psychiatry
- Harmonized identifiers (openFDA)
- Application number
- NDA208510
- Brand name
- VYVANSE
- Generic name
- LISDEXAMFETAMINE DIMESYLATE
- Manufacturer name
- Takeda Pharmaceuticals America, Inc.
- Product NDC
- 59417-118, 59417-101, 59417-102, 59417-103, 59417-104, 59417-105, 59417-106, 59417-107, 59417-115, 59417-116, 59417-117, 59417-119, 59417-120
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- LISDEXAMFETAMINE DIMESYLATE
- RxCUI
- 854830, 854832, 854834, 854836, 854838, 854840, 854842, 854844, 854846, 854848, 854850, 854852, 1593856, 1593858, 1871456, 1871459, 1871460, 1871461, 1871462, 1871463, 1871464, 1871465, 1871466, 1871467, 1871468, 1871469
- SPL ID
- 81d087b6-4cb4-466a-9693-679edeb062e2
- SPL set ID
- 704e4378-ca83-445c-8b45-3cfa51c1ecad
- Package NDC
- 59417-101-10, 59417-102-10, 59417-103-10, 59417-104-10, 59417-105-10, 59417-106-10, 59417-107-10, 59417-115-01, 59417-116-01, 59417-117-01, 59417-118-01, 59417-119-01, 59417-120-01
- UNII
- SJT761GEGS